Domestic production gets a boost as India steps closer to API self-reliance The Government of India has announced a significant milestone in its push for pharmaceutical self-reliance under the Production Linked Incentive (PLI) Scheme for Bulk Drugs, revealing that the initiative has led to import savings
Government’s Initiative to Reduce Import Dependence on China and Boost Domestic API ManufacturingThe Government of India is taking decisive steps to enhance domestic manufacturing of Active Pharmaceutical Ingredients (APIs), Key Starting Materials (KSMs), and Drug Intermediates (DIs) through the Production Linked Incentive (PLI) Scheme. This
The PHD Chamber of Commerce and Industry (PHDCCI) and the Association of Indian Medical Devices (AiMed), in alliance with the Manufacturers of Imaging, Therapy and Radiology Devices Association (MITRA), the Association of Diagnostic Manufacturers of India (ADMI), and key stakeholders from the MedTech industry, held
